glp-1 quiz 2 | Freya Test Your Knowledge: AARP's April
Description
Liraglutide (daily injectable) Dosing frequency: Once daily, same time each day Half-life: approximately 13 hours Peak concentration: 8 to 12 hours after injection Recommended timing approach: Because of the short half-life, time of day matters significantly more for liraglutide than for weekly formulations

Using the findings of in vitro, in vivo, and clinical investigations, the positive effects of these medications on UC are thoroughly outlined and examined in the present research

But what stood out to me was what wasnt there: almost no mention of potential downsides like shipping hiccups or billing frustrations

In the longer term, reduced obesity rates among Medicaid enrollees could also result in reduced Medicaid spending on chronic diseases associated with obesity, though the evidence is mixed

Marassi et al., 2025

All authors agree to be accountable for all aspects of the work
